BUZZ-Australia's Telix Pharmaceuticals jumps; UBS says shares undervalued

Reuters
08 Apr
BUZZ-Australia's Telix Pharmaceuticals jumps; UBS says shares undervalued

** Telix Pharmaceuticals TLX.AX jumps as much as 7.4% to A$24.87; marks biggest intraday pct gain since February 21

** Stock declined for last five straight sessions, hurt by soured investor sentiment amid global trade war

** UBS says shares look undervalued, given that co is profitable and manufactures its U.S.-sold products within the country and hence impacted minimally by tariffs

** YTD, TLX up 0.7%

(Reporting by Nichiket Sunil in Bengaluru)

((Nichiket.Sunil@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10